New patent expiration for Novo Nordisk drug NOVOLOG MIX 50/50
Annual Drug Patent Expirations for NOVOLOG+MIX+50%2F50 Novolog Mix 50/50 is a drug marketed by Novo Nordisk Inc and is included in one NDA. There is one patent protecting this drug.…
The post New patent expiration for Novo Nordisk drug NOVOLOG MIX 50/50 appeared first on DrugPatentWatch.
Comments are closed.